Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate
Clinical trial NCT02393378 · TERMINATED
Trial details
- NCT number
- NCT02393378
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-08
- Primary completion
- 2016-06-27
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.